Ingevity Corporation (NYSE: NGVT) announced that its Evotherm P35 warm-mix additive has received approval from Germany's Federal Highway Research Institute, known as BASt, for use in warm-mix asphalt applications.

The approval followed several years of technical evaluation, including performance testing alongside conventional hot-mix asphalt under real-world traffic and environmental conditions. BASt determined that Evotherm P35 met the durability and long-term performance criteria required for federal use in Germany.

"The BASt approval reflects how our technology aligns with the performance, environmental and regulatory priorities shaping the German market," said Dale Willis, global vice president of strategy and innovation, Pavement Technologies. "It underscores the strength of our formulation expertise and our ability to meet rigorous technical standards in complex regulatory environments."

According to a press release statement, the approval positions Evotherm P35 for use in what the company describes as one of Europe's most demanding regulatory environments. Ingevity noted the product incorporates bio-based materials intended to support performance and sustainability objectives.

Ingevity is headquartered in North Charleston, South Carolina, and operates from 17 locations worldwide with approximately 1,400 employees.